New Set of Recommendations Can Help Pharmacy Practice Authors Pick Best Journal to Publish Research
February 28th 2023The set of principles seeks to improve publication patterns to show the value of the pharmacist and how journals can strengthen pharmacy practice as a scientific discipline.
Read More
FDA Approves First-in-Class Factor VIII Therapy for Hemophilia A
February 24th 2023Altuviiio [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl; Sanofi] is high-sustained factor VIII replacement therapy indicated for routine prophylaxis and on-demand treatment to control bleeding episodes and for perioperative management in adults and children with hemophilia A.
Read More